MD Anderson to collaborate with Xilis for accelerated development of new cancer therapies
Image Source:- >> | Content Source:- >> The University of Texas MD Anderson Cancer Institute and the biotech firm Xilis have entered into a strategic partnership to advance science and hasten the development of novel cancer therapies. The partnership will enhance the development of cancer therapies by combining MD...